Pfizer PFE
NYSE PFE
$30.17 +0.73 (+2.50%)
As of: Oct 20, 2026 · 3:35 PM EDT

Pfizer (PFE) Operating Income (2009 - 2026)

Updated

Pfizer's Operating Income came in at $4.27 billion for Q2 2026, down 15.6% from $5.05 billion a year earlier and down 20.3% from the prior quarter.

Analysis

Pfizer (PFE) Operating Income (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 28, 2026, Pfizer reported Operating Income of $20.39 billion, up 1.5% year-over-year; for FY2025, it was $20.73 billion, up 16.4% from FY2024.

  • Operating Income carries a five-year compound annual growth rate of 11.0% (FY2020 to FY2025).
  • Going back by year, Operating Income was $17.81 billion in FY2024 (+186.9%), $6.21 billion in FY2023 (-84.6%), $40.35 billion in FY2022 (+51.7%) and $26.6 billion in FY2021 (+116.6%).
  • The Q2 2026 figure represents the lowest quarterly Operating Income since Q4 2024.
  • Year-over-year, Operating Income increased in four of the last six quarters, with growth averaging 19.8%.
  • The fastest year-over-year change in Operating Income over five years came in Q3 2021 (growth of 137.5%), and the weakest in Q2 2023 (a decline of 73.8%).
  • Business Quant data shows PFE's Operating Income at $5.35 billion (Q1 2026), $4.31 billion (Q4 2025) and $6.46 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,147.40 Bn 1,115.99 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 623.11 Bn 541.63 Bn 17.26 Bn 7.14 Bn
3 AbbVie 509.31 Bn 482.42 Bn 12.70 Bn 6.43 Bn
4 Merck 365.84 Bn 320.22 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.62 Bn 235.30 Bn 12.86 Bn 3.16 Bn
7 Amgen 235.65 Bn 191.05 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn -10.39 Bn
9 Pfizer 171.97 Bn 118.61 Bn 10.94 Bn 4.27 Bn
10 Vertex Pharmaceuticals 130.26 Bn 102.27 Bn 2.84 Bn 1.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 4.27 Bn
Mar 29, 2026 5.35 Bn
Dec 31, 2025 4.31 Bn
Sep 28, 2025 6.46 Bn
Jun 29, 2025 5.05 Bn
Mar 30, 2025 4.96 Bn
Dec 31, 2024 3.80 Bn
Sep 29, 2024 6.28 Bn
Jun 30, 2024 2.32 Bn
Mar 31, 2024 5.41 Bn
Dec 31, 2023 -2.95 Bn
Oct 1, 2023 -1.93 Bn
Jul 2, 2023 3.41 Bn
Apr 2, 2023 7.72 Bn
Dec 31, 2022 6.43 Bn
Oct 2, 2022 10.29 Bn
Jul 3, 2022 13.04 Bn
Apr 3, 2022 10.59 Bn
Dec 31, 2021 6.42 Bn
Oct 3, 2021 7.88 Bn
API Access

Pfizer Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=PFE&period=max&api_key=YOUR_API_KEY